Sun Pharmaceutical Industries Ltd Announces US FDA Approval for Generic Diltiazem ER(R)  
11/18/2010 11:56:33 AM

MUMBAI, India--(BUSINESS WIRE)--Sun Pharmaceutical Industries Ltd. (Reuters: SUN.BO, Bloomberg: SUNP IN, NSE:SUNPHARMA, BSE: 524715) announced that USFDA has granted its subsidiary an approval for its Abbreviated New Drug Application (ANDA) to market a generic version of once-a-day TiazacĀ® extended release capsules.